Cargando…

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer

BACKGROUND: Circulating tumor cells (CTC) and plasma cell-free RNA (cfRNA) can serve as biomarkers for prognosis and treatment response in lung cancer. One barrier to the selected or routine use of CTCs and plasma cfRNA in precision oncology is the limited quantity of both, and CTCs are only seen in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beck, Tim N., Boumber, Yanis A., Aggarwal, Charu, Pei, Jianming, Thrash-Bingham, Catherine, Fittipaldi, Patricia, Vlasenkova, Ramillya, Rao, Chandra, Borghaei, Hossein, Cristofanilli, Massimo, Mehra, Ranee, Serebriiskii, Ilya, Alpaugh, R. Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582501/ https://www.ncbi.nlm.nih.gov/pubmed/31215484 http://dx.doi.org/10.1186/s12885-019-5795-x

Ejemplares similares

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
por: Fernandez, Sandra V, et al.
Publicado: (2014)

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
por: Bingham, Catherine, et al.
Publicado: (2017)

CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma
por: Makhov, Peter, et al.
Publicado: (2020)

Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
por: Aggarwal, Charu, et al.
Publicado: (2009)

Treatment Paradigms for Advanced Non‐Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design
por: Aggarwal, Charu, et al.
Publicado: (2017)

Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
por: Deneka, Alexander Y., et al.
Publicado: (2019)

Phospho-(T356)RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
por: Beck, Tim N., et al.
Publicado: (2015)

Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
por: Khaddour, Karam, et al.
Publicado: (2021)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
por: Arora, Sanjeevani, et al.
Publicado: (2019)

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
por: Makhov, Petr, et al.
Publicado: (2021)

NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma
por: Topchu, Iuliia, et al.
Publicado: (2023)

Case report: reinitiating pembrolizumab treatment after small bowel perforation
por: Beck, Tim N., et al.
Publicado: (2019)

Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
por: Topchu, Iuliia, et al.
Publicado: (2021)

Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma
por: Nicolas, Emmanuelle, et al.
Publicado: (2019)

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
por: Khaddour, Karam, et al.
Publicado: (2020)

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
por: Mu, Zhaomei, et al.
Publicado: (2013)

Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
por: Jung, Kyungsuk, et al.
Publicado: (2018)

NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
por: Peri, Suraj, et al.
Publicado: (2017)

The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma
por: Makhov, Peter, et al.
Publicado: (2018)

Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells
por: Kondo, Yutaka, et al.
Publicado: (2008)

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer
por: Bychkov, Igor, et al.
Publicado: (2023)

Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer
por: Bychkov, Igor, et al.
Publicado: (2023)

Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents
por: Gusakov, Evgeniy A., et al.
Publicado: (2021)

CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome
por: Raghavakaimal, Ashvathi, et al.
Publicado: (2022)

Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing
por: Demidova, Elena V., et al.
Publicado: (2023)

Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing
por: Demidova, Elena V., et al.
Publicado: (2023)

Numb Independently Antagonizes Sanpodo Membrane Targeting and Notch Signaling in Drosophila Sensory Organ Precursor Cells
por: Tong, Xin, et al.
Publicado: (2010)

Tumor Cell Capture Using Platelet-Based and Platelet-Mimicking Modified Human Serum Albumin Submicron Particles
por: Zhao, Xiaotong, et al.
Publicado: (2022)

Epigenetic Inactivation of Notch-Hes Pathway in Human B-Cell Acute Lymphoblastic Leukemia
por: Kuang, Shao-Qing, et al.
Publicado: (2013)

Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer
por: Winn, Jennifer S., et al.
Publicado: (2020)

How I treat ALK-positive non-small cell lung cancer
por: McCusker, Michael G, et al.
Publicado: (2019)

An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion
por: Beck, Tim N., et al.
Publicado: (2019)

Personalized medicine and treatment approaches in non-small-cell lung carcinoma
por: Vadakara, Joseph, et al.
Publicado: (2012)

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
por: Adams, Daniel L., et al.
Publicado: (2016)

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing
por: Fernandez, Sandra V., et al.
Publicado: (2023)

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas
por: Ho, Won Jin, et al.
Publicado: (2018)

Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin
por: Skripova, Vera, et al.
Publicado: (2022)

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
por: Tejani, Mohamedtaki A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_idh1u01jchiu06cq1ir7bp5u2i